BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20473944)

  • 1. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells.
    Hehlgans T; Müller P; Stopfer P; Männel DN
    Eur Cytokine Netw; 2003; 14(2):103-7. PubMed ID: 12957791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotoxin β receptor-mediated NFκB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem/progenitor cells.
    Xiao X; Putatunda R; Zhang Y; Soni PV; Li F; Zhang T; Xin M; Luo JJ; Bethea JR; Cheng Y; Hu W
    J Neuroinflammation; 2018 Feb; 15(1):49. PubMed ID: 29463313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.
    Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA
    Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis.
    Hehlgans T; Stoelcker B; Stopfer P; Müller P; Cernaianu G; Guba M; Steinbauer M; Nedospasov SA; Pfeffer K; Männel DN
    Cancer Res; 2002 Jul; 62(14):4034-40. PubMed ID: 12124338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
    Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
    Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin β receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFα and IL-1β in bladder cancer cells.
    Shen M; Zhou L; Zhou P; Zhou W; Lin X
    Mol Med Rep; 2017 Jul; 16(1):937-942. PubMed ID: 28586003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting lymphotoxin beta receptor with tumor-specific T lymphocytes for tumor regression.
    Yang D; Ud Din N; Browning DD; Abrams SI; Liu K
    Clin Cancer Res; 2007 Sep; 13(17):5202-10. PubMed ID: 17785576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin β receptor signalling executes
    Mejías-Luque R; Zöller J; Anderl F; Loew-Gil E; Vieth M; Adler T; Engler DB; Urban S; Browning JL; Müller A; Gerhard M; Heikenwalder M
    Gut; 2017 Aug; 66(8):1369-1381. PubMed ID: 27196595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
    Maracle CX; Kucharzewska P; Helder B; van der Horst C; Correa de Sampaio P; Noort AR; van Zoest K; Griffioen AW; Olsson H; Tas SW
    Rheumatology (Oxford); 2017 Feb; 56(2):294-302. PubMed ID: 27864565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
    Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
    Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner.
    Wimmer N; Huber B; Wege AK; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
    Mol Immunol; 2012 Jun; 51(2):128-35. PubMed ID: 22437076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells.
    Stopfer P; Männel DN; Hehlgans T
    J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.
    Giles DA; Zahner S; Krause P; Van Der Gracht E; Riffelmacher T; Morris V; Tumanov A; Kronenberg M
    Front Immunol; 2018; 9():2585. PubMed ID: 30524422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
    Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
    J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.